- home
- Advanced Search
Advanced search in Research outcomes
Filters
Clear AllFilters
Clear AllLoading
- publication . Article . Preprint . 2022EmbargoAuthors:Martin Šmíd; Luděk Berec; Lenka Přibylová; Ondřej Májek; Tomáš Pavlík; Jiří Jarkovský; Jakub Weiner; Tamara Barusová; Jan Trnka;Persistent IdentifiersPublisher: Oxford University Press (OUP)
The Omicron variant of the SARS-CoV-2 virus carries mutations, which enable it to evade immunity conferred by vaccines and previous infections. We used a Cox proportional hazards model and a logistic regression model on individual-level data on all laboratory-confirmed ...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Lidya Handayani Tjan; Koichi Furukawa; Yukiya Kurahashi; Silvia Sutandhio; Mitsuhiro Nishimura; Jun Arii; Yasuko Mori;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022Open AccessAuthors:Tsun-Yung Kuo; Chia En Lien; Yi-Jiun Lin; Meei-Yun Lin; Chung-Chin Wu; Wei-Hsuan Tang; John D. Campbell; Paula Traquina; Ya-Shan Chuang; Luke Tzu-Chi Liu; ...Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract SARS-CoV-2 Variants of Concern (VoCs) negatively impact the effectiveness of vaccines. In this study, we challenge hamsters with the Delta variant after two- or three-dose inoculations with SARS-CoV-2 vaccines constructed from stabilized prefusion spike protein...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Nadine Peart Akindele; Lisa Pieterse; San Suwanmanee; Diane E Griffin;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract Multisystem inflammatory syndrome in children (MIS-C) can complicate infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but differences in the immune responses during MIS-C compared to coronavirus disease 2019 (COVID-19) are poorly und...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Chen Chen; Spencer R. Haupert; Lauren Zimmermann; Xu Shi; Lars G. Fritsche; Bhramar Mukherjee;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract Introduction This study aims to examine the worldwide prevalence of post COVID-19 condition, through a systematic review and meta-analysis. Methods PubMed, Embase, and iSearch were searched on July 5, 2021 with verification extending to March 13, 2022. Using...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Brandon J. Beddingfield; Lori A. Rowe; Kasi E. Russell-Lodrigue; Lara A. Doyle-Meyers; Nadia Golden; Skye Spencer; Nicole Chirichella; Robert V. Blair; Nicholas J. Maness; Chad J. Roy;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract Breakthrough gastrointestinal COVID was observed after experimental SARS-CoV-2 upper mucosal infection in a rhesus macaque undergoing low-dose monoclonal antibody prophylaxis. High levels of viral RNA were detected in intestinal sites contrasting with minimal v...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022Open AccessAuthors:Mathieu Le Gars; Jerald Sadoff; Frank Struyf; Dirk Heerwegh; Carla Truyers; Jenny Hendriks; Glenda Gray; Beatriz Grinsztejn; Paul A. Goepfert; Hanneke Schuitemaker; ...Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract This secondary analysis of the phase 3 ENSEMBLE trial (NCT04505722) assessed the impact of preexisting humoral immunity to adenovirus type 26 (Ad26) on the immunogenicity of Ad26.COV2.S-elicited SARS-CoV-2–specific antibody levels in 380 participants in Brazil,...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Shekhar Ghamande; Nicholas Mohr;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract Background The study objective was to evaluate 2 and 3 dose COVID-19 mRNA vaccine effectiveness (VE) in preventing COVID-19 hospitalization among adult solid organ transplant (SOT) recipients. Methods 21-site case-control analysis of 10,425 adults hospitaliz...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Jenny S Maron; Michelle Conroy; Vivek Naranbai; Upeka Samarakoon; Tina Motazedi; Jocelyn R Farmer; Esther Freeman; Aleena Banerji; Yannic C Bartsch; David J Gregory; ...Persistent IdentifiersPublisher: Oxford University Press (OUP)
Abstract Allergic symptoms after messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines occur in up to 2% of recipients. Compared to nonallergic controls (n = 18), individuals with immediate allergic reactions to mRNA COVID-19 vaccines (n = 8) mounted lower i...
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome. - publication . Article . 2022EmbargoAuthors:Nevio Cimolai;Persistent IdentifiersPublisher: Oxford University Press (OUP)
Add to ORCID Please grant OpenAIRE to access and update your ORCID works.This research outcome is the result of merged research outcomes in OpenAIRE.
You have already added works in your ORCID record related to the merged research outcome.